Zion Urgent Care
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Craig, David
CAPTURE-2, NCT04597047: Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test

Active, not recruiting
N/A
153
US
Capillary Collection & Testing, Venous Draw & Testing
LumiraDx UK Limited
Covid19
12/20
09/23
ASPIRE, NCT04557046: Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

Active, not recruiting
N/A
1134
US
Nasal Swab, Nasopharyngeal swab, Throat swab, Fingerstick, Saliva specimen
LumiraDx UK Limited
Covid19
03/21
03/24
ASPIRE-2, NCT05506618: Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test

Active, not recruiting
N/A
400
US
Nasal Swab, Nasopharyngeal swab
LumiraDx UK Limited
COVID-19
10/22
04/23
Teketel, Tewodros
FORTIS, NCT05126901: Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

Completed
3
65
Europe, US
Ferric Maltol, Feraccru, Ferric Trimaltol, ST10, ST10-01, Ferrous sulfate
Shield Therapeutics
Anemia, Iron-deficiency
06/24
06/24
NCT06063330: Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Completed
1
66
US
RQ-001, Placebo
Red Queen Therapeutics, Inc., PPD
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed, SARS CoV 2 Infection
01/24
01/24
ASPIRE-2, NCT05506618: Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test

Active, not recruiting
N/A
400
US
Nasal Swab, Nasopharyngeal swab
LumiraDx UK Limited
COVID-19
10/22
04/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Craig, David
CAPTURE-2, NCT04597047: Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test

Active, not recruiting
N/A
153
US
Capillary Collection & Testing, Venous Draw & Testing
LumiraDx UK Limited
Covid19
12/20
09/23
ASPIRE, NCT04557046: Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

Active, not recruiting
N/A
1134
US
Nasal Swab, Nasopharyngeal swab, Throat swab, Fingerstick, Saliva specimen
LumiraDx UK Limited
Covid19
03/21
03/24
ASPIRE-2, NCT05506618: Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test

Active, not recruiting
N/A
400
US
Nasal Swab, Nasopharyngeal swab
LumiraDx UK Limited
COVID-19
10/22
04/23
Teketel, Tewodros
FORTIS, NCT05126901: Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

Completed
3
65
Europe, US
Ferric Maltol, Feraccru, Ferric Trimaltol, ST10, ST10-01, Ferrous sulfate
Shield Therapeutics
Anemia, Iron-deficiency
06/24
06/24
NCT06063330: Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Completed
1
66
US
RQ-001, Placebo
Red Queen Therapeutics, Inc., PPD
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed, SARS CoV 2 Infection
01/24
01/24
ASPIRE-2, NCT05506618: Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test

Active, not recruiting
N/A
400
US
Nasal Swab, Nasopharyngeal swab
LumiraDx UK Limited
COVID-19
10/22
04/23

Download Options